CBSA Helps Launch We Work For Health Initiative in Colorado

Denver, CO, March 20, 2009 – The Colorado BioScience Association (CBSA) is partnering with twenty-six national and state entities to announce the ‘We Work For Health’ (WWFH) initiative in Colorado. The announcement is made by John Collar, CBSA President & CEO, who says the new group’s launch event – Saving Lives, Creating Jobs -- occurs today at University of Colorado Denver, Anschutz Medical Campus in Aurora. U.S. Senator Michael Bennet is the special guest speaker via satellite from Washington.

“The Colorado BioScience Association is absolutely thrilled to be a partner in the We Work For Health initiative in the state,” Collar says. “The United States, and our state in particular, has been a world leader in bioscience innovation and discovery over the years. Further, our universities and bioscience companies create thousands of high-paying jobs, and Colorado discoveries are integral in the fight to cure cancer and other illnesses. Today’s event is only first of many for the new initiative in our state.”

Link to the We Work For Health Colorado webpage

CBSA Included in March 15 Genetic Engineering News Article

Remarks included from CBSA's John Collar: Colorado is another bright spot. It has built its biosciences industry from scratch in this decade, thanks in great part to a state commitment that funded start-ups and built the necessary infrastructure.

"A lot of positive things are happening in Colorado," according to John Collar, executive director, Colorado Biosciences Association.

Although the state is facing a budget shortfall of some $604 million, "the legislative groups are doing a good job crafting a budget to go forward with the commitment to biosciences," including making funds available for proof-of-concept and early-stage companies, he says.



Link to the article

CBSA Featured In Winter 2009-09 European Life Science Journal

European Life Science is the premier journal devoted to presenting outstanding research and researchers within the life science fields in Europe.

As a cross-disciplinary journal, European Life Science, profiles all fields that provide new insight into the research development of human health and disease such as clinical advances in medicine, biotechnology, chemistry, drug discovery, genetics, material science, medical research, microbiology, molecular cell biology, neuroscience, pharmacology and physics. It also provides you with issues concerning intellectual property case law and policy.

Link to the ELSJ website

Link to the CBSA article pdf

February 2009 Med Ad News Placement

Quote from CBSA and President & CEO John Collar: The biotech industry does have one inherent advantage in tough times – some of the world’s most innovatory leaders. "Bioscience companies are renowned for excellent management teams," says John Collar, executive director of the Colorado BioScience Association (cobioscience.com). "They, of course, will keep a tight eye on the fundamentals of cost management and implementing innovative lean operational measures, while narrowly focusing on developing products and services with significant market potentials. Firms that bring innovative, lower cost, and more effective products and services to market will not only survive these times, but will be the powerhouses of the industry going forward."

Link to the full article (subscription required)